BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 25808006)

  • 1. Xenobiotic metabolizing enzymes in human skin and SkinEthic reconstructed human skin models.
    Eilstein J; Léreaux G; Arbey E; Daronnat E; Wilkinson S; Duché D
    Exp Dermatol; 2015 Jul; 24(7):547-9. PubMed ID: 25808006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of xenobiotic metabolizing enzyme activities in ex vivo human skin and reconstructed human skin models from SkinEthic.
    Eilstein J; Léreaux G; Budimir N; Hussler G; Wilkinson S; Duché D
    Arch Toxicol; 2014 Sep; 88(9):1681-1694. PubMed ID: 24658324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Xenobiotic metabolism capacities of human skin in comparison with a 3D-epidermis model and keratinocyte-based cell culture as in vitro alternatives for chemical testing: phase II enzymes.
    Götz C; Pfeiffer R; Tigges J; Ruwiedel K; Hübenthal U; Merk HF; Krutmann J; Edwards RJ; Abel J; Pease C; Goebel C; Hewitt N; Fritsche E
    Exp Dermatol; 2012 May; 21(5):364-9. PubMed ID: 22509834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of xenobiotic metabolizing enzymes of a reconstructed human epidermal model from adult hair follicles.
    Bacqueville D; Jacques C; Duprat L; Jamin EL; Guiraud B; Perdu E; Bessou-Touya S; Zalko D; Duplan H
    Toxicol Appl Pharmacol; 2017 Aug; 329():190-201. PubMed ID: 28601433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Xenobiotic metabolism capacities of human skin in comparison with a 3D epidermis model and keratinocyte-based cell culture as in vitro alternatives for chemical testing: activating enzymes (Phase I).
    Götz C; Pfeiffer R; Tigges J; Blatz V; Jäckh C; Freytag EM; Fabian E; Landsiedel R; Merk HF; Krutmann J; Edwards RJ; Pease C; Goebel C; Hewitt N; Fritsche E
    Exp Dermatol; 2012 May; 21(5):358-63. PubMed ID: 22509833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Xenobiotic metabolism gene expression in the EpiDermin vitro 3D human epidermis model compared to human skin.
    Hu T; Khambatta ZS; Hayden PJ; Bolmarcich J; Binder RL; Robinson MK; Carr GJ; Tiesman JP; Jarrold BB; Osborne R; Reichling TD; Nemeth ST; Aardema MJ
    Toxicol In Vitro; 2010 Aug; 24(5):1450-63. PubMed ID: 20350595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Xenobiotica-metabolizing enzymes in the skin of rat, mouse, pig, guinea pig, man, and in human skin models.
    Oesch F; Fabian E; Landsiedel R
    Arch Toxicol; 2018 Aug; 92(8):2411-2456. PubMed ID: 29916051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of human in vitro skin models for accurate and ethical risk assessment: metabolic considerations.
    Hewitt NJ; Edwards RJ; Fritsche E; Goebel C; Aeby P; Scheel J; Reisinger K; Ouédraogo G; Duche D; Eilstein J; Latil A; Kenny J; Moore C; Kuehnl J; Barroso J; Fautz R; Pfuhler S
    Toxicol Sci; 2013 Jun; 133(2):209-17. PubMed ID: 23539547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dermal xenobiotic metabolism: a comparison between native human skin, four in vitro skin test systems and a liver system.
    Wiegand C; Hewitt NJ; Merk HF; Reisinger K
    Skin Pharmacol Physiol; 2014; 27(5):263-75. PubMed ID: 24943921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression profiles of phases 1 and 2 metabolizing enzymes in human skin and the reconstructed skin models Episkin and full thickness model from Episkin.
    Luu-The V; Duche D; Ferraris C; Meunier JR; Leclaire J; Labrie F
    J Steroid Biochem Mol Biol; 2009 Sep; 116(3-5):178-86. PubMed ID: 19482084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Skin metabolism phase I and phase II enzymes in native and reconstructed human skin: a short review.
    Kazem S; Linssen EC; Gibbs S
    Drug Discov Today; 2019 Sep; 24(9):1899-1910. PubMed ID: 31176740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sex-dependent metabolism of xenobiotics.
    Mugford CA; Kedderis GL
    Drug Metab Rev; 1998 Aug; 30(3):441-98. PubMed ID: 9710703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Xenobiotic metabolism in human skin and 3D human skin reconstructs: a review.
    Gibbs S; van de Sandt JJ; Merk HF; Lockley DJ; Pendlington RU; Pease CK
    Curr Drug Metab; 2007 Dec; 8(8):758-72. PubMed ID: 18220556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Label-Free Quantitative Proteomics and Substrate-Based Mass Spectrometry Imaging of Xenobiotic Metabolizing Enzymes in Ex Vivo Human Skin and a Human Living Skin Equivalent Model.
    Couto N; Newton JRA; Russo C; Karunakaran E; Achour B; Al-Majdoub ZM; Sidaway J; Rostami-Hodjegan A; Clench MR; Barber J
    Drug Metab Dispos; 2021 Jan; 49(1):39-52. PubMed ID: 33139459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Xenobiotic metabolizing enzyme activities in cells used for testing skin sensitization in vitro.
    Fabian E; Vogel D; Blatz V; Ramirez T; Kolle S; Eltze T; van Ravenzwaay B; Oesch F; Landsiedel R
    Arch Toxicol; 2013 Sep; 87(9):1683-96. PubMed ID: 23958860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Final report on the safety assessment of human placental protein, hydrolyzed human placental protein, human placental enzymes, human placental lipids, human umbilical extract, placental protein, hydrolyzed placental protein, placental enzymes, placental lipids, and umbilical extract.
    Nair B; Elmore AR;
    Int J Toxicol; 2002; 21 Suppl 1():81-91. PubMed ID: 12042062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of metabolizing enzymes by bisphenol a in human and animal models.
    Quesnot N; Bucher S; Fromenty B; Robin MA
    Chem Res Toxicol; 2014 Sep; 27(9):1463-73. PubMed ID: 25142872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Interindividual differences in efficacy and toxicity induced by therapeutic drugs and xenobiotics in relation to genetic polymorphisms in xenobiotic metabolizing enzymes].
    Ozawa S
    Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku; 1998; (116):69-81. PubMed ID: 10097514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extrahepatic metabolism at the body's internal-external interfaces.
    Gundert-Remy U; Bernauer U; Blömeke B; Döring B; Fabian E; Goebel C; Hessel S; Jäckh C; Lampen A; Oesch F; Petzinger E; Völkel W; Roos PH
    Drug Metab Rev; 2014 Aug; 46(3):291-324. PubMed ID: 24666398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nasal cavity enzymes involved in xenobiotic metabolism: effects on the toxicity of inhalants.
    Dahl AR; Hadley WM
    Crit Rev Toxicol; 1991; 21(5):345-72. PubMed ID: 1741949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.